Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05525247
Title A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Selecxine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Selecxine Investigator site NOT_YET_RECRUITING Sarasota Florida 34232 United States Details
Selecxine Investigator site RECRUITING Detroit Michigan 48201 United States Details
Selecxine Investigator site NOT_YET_RECRUITING Oklahoma City Oklahoma 73104 United States Details
Selecxine Investigator site NOT_YET_RECRUITING Waratah New South Wales 2298 Australia Details
Selecxine Investigator site NOT_YET_RECRUITING Brentwood Perth 6153 Australia Details
Selecxine Investigator site RECRUITING Seoul Jongno-gu 03080 Korea, Republic of Details
Selecxine Investigator site RECRUITING Seoul Seodaemun-gu 03722 Korea, Republic of Details
Selecxine Investigator site NOT_YET_RECRUITING Gyeonggi-do Seongnam-si 13620 Korea, Republic of Details
Selecxine Investigator site RECRUITING Seoul Songpa-gu 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field